Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Medical psychiatry

Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland Laboratory of Genetic Neuropharmacology, McLean Hospital, Department of Psychiatry, Harvard Medical School, Belmont, MA, USA... [Pg.515]

RGURE31-1. Beck Depression Inventory, Siort Form. (Rom Beck, A. T., Ward, C H., Men del son, M., et al. [1961 ]. An inventory for measuring depression. Archives of General Psychiatry 4 561 -57. Copyright 1961. American Medical Association. Used with permission.)... [Pg.288]

Nestler EJ, Hyman SE, Malenka RC Molecular Neuropharmacology A Foundation for Clinical Neuroscience. New York, McGraw Hill, 2001 Novick DM, Pascarelli EE, Joseph H, et al Methadone maintenance patients in general medical practice a preliminary report. JAMA 259 3299—3302, 1988 Nunes EV, Quitkin EM, Donovan SJ, et al. Imipramine treatment of opiate-dependent patients with depressive disorders a placebo-controlled trial. Arch Gen Psychiatry 55 153-160, 1998... [Pg.105]

Umbricht A, Hoover DR, Tucker MJ, et al Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection. Drug Alcohol Depend 69 263-272, 2003 Villagomez RE, Meyer TJ, Lin MM, et al Post-traumatic stress disorder among inner city methadone maintenance patients. Subst Abuse Treat 12 253—257, 1995 Mining E, Kosten TR, Kleber H Clinical utility of rapid clonidine-naltrexone detoxification for opioid abusers. Br J Addict 83 567-575, 1988 Washton AM, Pottash AC, Gold MS Naltrexone in addicted business executives and physicians. J Clin Psychiatry 45 39 1, 1984 Wesson DR Revival of medical maintenance in the treatment of heroin dependence (editorial). JAMA 259 3314-3315, 1988... [Pg.109]

Gottschalk LA, Bates DE, Fox RA, et al Psychoactive drug use patterns found in samples from a mental health clinic and a general medical clinic. Arch Gen Psychiatry 25 395-397, 1971... [Pg.153]

Klein E, Uhde TW, Post RM Preliminary evidence for the utility of carbamazepine in alprazolam withdrawal. Am J Psychiatry 143 235—236, 1986 Kouyanou K, Pither CE, Wessely S Medication misuse, abuse and dependence in chronic pain patients. J Psychosom Res 43 497-304, 1997 Kryspin-Exner K [Misuse of bezodiazepine derivatives in alcoholics] (German). Br J Addict Alcohol Other Drugs 61 283-290, 1966 Kryspin-Exner K, Demel 1 The use of tranquilizers in the treatment of mixed drug abuse. Int J Clin Pharmacol Biopharm 12 13-18, 1973... [Pg.155]

George TP, Ziedonis DM, Feingold A, et al Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. Am J Psychiatry 157 1835-1842, 2000... [Pg.335]

Higgins ST, Sigmon SC, Wong CJ, et al Community reinforcement therapy for cocaine-dependent outpatients. Arch Gen Psychiatry 60 1043—1052, 2003 Hopkins JS, Garbutt JC, Poole CL, et al Naltrexone and acamprosate meta-analysis of two medical treatments for alcoholism. Presented at the 25th annual meeting of the Research Society on Alcoholism, San Francisco, CA, June 28—July 3, 2002... [Pg.359]

Psychiatrist-in-Chief, Boston Medical Center Professor and Chair, Division of Psychiatry, Boston University School of Medicine, Boston, Massachusetts... [Pg.398]

Professor of Psychiatry (Pharmacology), Harvard Medical School, Boston, Massachusetts Director, Behavioral Psychopharmacology Research Laboratory, McLean Hospital, Belmont, Massachusetts... [Pg.399]

Katon W (1996). Panic disorder relationship to high medical utilization, unexplained physical symptoms, and medical costs. J Clin Psychiatry 57 (suppl. 10), 11-18. [Pg.67]

Malcolm Lader is an external member of the Scientific Staff of the Medical Research Council, UK, and Professor of Clinical Psychopharmacology at the Institute of Psychiatry, Kings College London, University of London. Professor Lader is also an... [Pg.117]

Psychiatry Department, Brentwood Divison West Los Angeles VA Medical Center and UCLA School of Medicine 11301 Wilshire Boulevard Los Angeles, CA 90073... [Pg.241]

Suppes T, Dennehy EB, Hirschfeld RM, et al. The Texas implementation of medication algorithms update to the algorithms for treatment of bipolar I disorder. J Clin Psychiatry 2005 66 870-886. [Pg.604]

Associate Professor of Psychiatry University of Michigan Medical School Executive Director... [Pg.1686]

Si, T. M., Shu, L., Yu, X. et al. (2005b). A cross-sectional study on medication treatment patterns of bipolar disorder in China. Chinese Journal of Psychiatry, 38(3), 165-9. [Pg.95]

Mendoza, R. Smith, M. (2000). The Hispanic response to psychotropic medications. In P. Ruiz, ed., Ethnicity and Psychopharmacology. (Review of Psychiatry Series, Vol. 19, No. 4 J. O. Oldham and M. B. Riba series eds.) Washington, DC American Psychiatric Press, pp. [Pg.109]

Opolka, J. L., Rascati, K. L., Brown, C. M., Barner, J. C. et al. (2003). Ethnic differences in use of antipsychotic medication among Texas Medicaid clients with schizophrenia. /. Clin. Psychiatry, 64, 635-9. [Pg.109]

Research in psychopharmacology has shown that ethnicity must be considered in psychiatry as well (Lawson, 1986 Pi 8c Simpson, 2005). Early clinical trials with antipsychotic and antidepressant medications showed that ethnic minorities may respond when given the same doses as Caucasians, and may have more side effects (Lawson, 1986 Lawson, 1990). However, dosing cannot be used as a measure of appropriate pharmacotherapy because an extensive literature has shown that African Americans often receive higher doses of antipsychotics despite evidence of more side effects. [Pg.112]

Fenton, W. S. Chavez, M. R. (2006). Medication-induced weight gain and dyslipidemia in patients with schizophrenia. Am. J. Psychiatry, 163, 1697-704. [Pg.116]

Kilbourne, A. M. 8c Pincus, H. A. (2006). Patterns of psychotropic medication use by race among veterans with bipolar disorder. Psychiatry Serv., 57, 123-6. [Pg.116]

Lindamer, L., Lacro, J. P. Jeste, D.V. (1999). Relationship of ethnicity to the effects of antipsychotic medication. In J. M. Herrara, W. B. Lawson and J. J. Sramek, eds., Cross Cultural Psychiatry. Sussex John Wiley Sons. [Pg.116]

Morgenstern, H. Glazer, W. M (1993). Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications results of the Yale Tardive Dyskinesia Study. Arch. Gen. Psychiatry, 50, 723-33. [Pg.116]

David Geffen School of Medicine, Dept, of Psychiatry, Harbor-UCLA Medical Center Torrance, CA, USA... [Pg.196]

Evidence-Based Medicine. Evidence-Based Medicine [45] consists of summarized abstracts of articles on family medicine, internal medicine, general surgery, pediatrics, obstetrics, gynecology, psychiatry, and anesthesiology with commentary by clinical experts. More than 50 peer-reviewed medical journals are abstracted. Also included are key selections from ACP Journal Club. Evidence-Based Medicine is commercially available however, its distribution is restricted and does not include North, Central, or South America. [Pg.768]


See other pages where Medical psychiatry is mentioned: [Pg.373]    [Pg.197]    [Pg.211]    [Pg.373]    [Pg.197]    [Pg.211]    [Pg.47]    [Pg.97]    [Pg.101]    [Pg.151]    [Pg.152]    [Pg.159]    [Pg.35]    [Pg.232]    [Pg.18]    [Pg.82]    [Pg.107]    [Pg.110]    [Pg.119]    [Pg.132]    [Pg.152]    [Pg.154]    [Pg.164]    [Pg.169]    [Pg.768]    [Pg.37]   
See also in sourсe #XX -- [ Pg.211 , Pg.213 ]




SEARCH



Psychiatry

© 2024 chempedia.info